IO Biotech, Inc.
IOBT
$1.72
$0.010.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.74% | -15.23% | -19.67% | -10.78% | 2.32% |
| Total Depreciation and Amortization | 9.35% | 7.58% | 8.96% | 5.67% | 14.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 178.19% | -17.50% | 446.49% | -98.44% | 7.37% |
| Change in Net Operating Assets | -23.73% | 66.93% | 155.19% | 36.32% | 57.58% |
| Cash from Operations | -16.72% | 7.46% | 13.91% | -30.13% | 7.01% |
| Capital Expenditure | -116.67% | -154.55% | 90.18% | 58.33% | 69.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -116.67% | -154.55% | 90.18% | 58.33% | 69.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -146.47% | 157.46% | -185.06% | 156.89% | -83.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.04% | 8.99% | 9.66% | -137.11% | 6.49% |